Drugs Not Included in Groups A - C and Rationale for Non-inclusion
H5Content
Drugs Used in the Management of Adverse Events
Rationale for Grouping of Anti-TB Drugs
Drugs Not Included in Groups A - C and Rationale for Non-inclusion
Eligibility Criteria for the Use of Bedaquiline [Bdq] in MDR/RR-TB Treatment
Bedaquiline Drug Dosages and Duration
Eligibility Criteria for the Use of Delamanid [Dlm] in MDR/RR-TB Treatment
Doses and duration of treatment with Delamanid